Nov 6 (Reuters) - PYC Therapeutics Ltd (PYC) :
- HELD PRE-IND MEETING WITH US FDA AND AGREED ON PROPOSED PATHWAY THROUGH CLINICAL TRIALS FOR DRUG CANDIDATE
- ALIGNED WITH US FDA FOR CLINICAL TRIALS OF ITS INVESTIGATIONAL DRUG CANDIDATE FOR AUTOSOMAL DOMINANT OPTIC ATROPHY
- EXPECTS TO PROGRESS DRUG CANDIDATE TO HUMAN TRIALS IN 1H 2024
News: PYC PYC Therapeutics Holds Pre-IND Meeting With US FDA
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
0.010(10.0%) |
Mkt cap ! $513.2M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 11.0¢ | 10.0¢ | $430.2K | 4.019M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 227514 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 1209313 | 12 |
View Market Depth
| Last trade - 16.10pm 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
11.0¢ |
Change
0.010 ( 10.0 %) |
||||
| Open | High | Low | Volume | ||
| 10.5¢ | 11.0¢ | 10.3¢ | 2812759 | ||
| Last updated 15.29pm 07/06/2024 ? | |||||
| PYC (ASX) Chart |